Followers | 11 |
Posts | 264 |
Boards Moderated | 0 |
Alias Born | 08/25/2019 |
Sunday, February 16, 2020 8:10:45 PM
We know there is a tremendous demand for tests and treatments in the female healthcare industry worldwide, and we know major pharmaceutical companies like Merck and Pfizer, and others, are getting out of the space.
We also know that PRED is targeting this same space, and through beta testing, we know the Artguide test is effective, and does what it promises.
Management has been clever enough to take care of finances w/the stem cell piece, as they continue working towards the predictive side of the company. Some may point to the falling stock price and two down quarters. It still doesn’t change the fact that PRED is making it work financially under their own steam, while they continue to grow the company with additional joint ventures.
Go review all of the acquisitions and mergers tied to PRED. Not a single company mentioned in these PRs has refuted PRED’s claims. Not one.
Go look at the early histories of pretty much any company that has made it big. Do you think their stock price had a straight linear graph trajectory to success? Do you think they had nothing but stellar quarterly financial reports in the beginning? Of course not. Give me a break.
We all know this intellectually, and yet somehow some of us forget these very important details when we see a stock price falling, and we let our emotions take over.
Be smarter than that.
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM